180 related articles for article (PubMed ID: 37245766)
21. Sinigrin Impedes the Breast Cancer Cell Growth through the Inhibition of PI3K/AKT/mTOR Phosphorylation-Mediated Cell Cycle Arrest.
Li S; Lin J; Wei J; Zhou L; Wang P
J Environ Pathol Toxicol Oncol; 2022; 41(3):33-43. PubMed ID: 35993954
[TBL] [Abstract][Full Text] [Related]
22. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway.
Zhou R; Chen H; Chen J; Chen X; Wen Y; Xu L
BMC Complement Altern Med; 2018 Mar; 18(1):83. PubMed ID: 29523109
[TBL] [Abstract][Full Text] [Related]
23. DMC triggers MDA-MB-231 cells apoptosis via inhibiting protective autophagy and PI3K/AKT/mTOR pathway by enhancing ROS level.
Jiang Y; Xu S; Guo M; Lu Z; Wei X; An F; Xin X
Toxicol In Vitro; 2024 May; 97():105809. PubMed ID: 38521250
[TBL] [Abstract][Full Text] [Related]
24. 6-Methoxydihydrosanguinarine induces apoptosis and autophagy in breast cancer MCF-7 cells by accumulating ROS to suppress the PI3K/AKT/mTOR signaling pathway.
Zhang L; Zhang X; Che D; Zeng L; Zhang Y; Nan K; Zhang X; Zhang H; Guo Z
Phytother Res; 2023 Jan; 37(1):124-139. PubMed ID: 36116140
[TBL] [Abstract][Full Text] [Related]
25. CLE-10 from
Tian L; Cheng F; Wang L; Qin W; Zou K; Chen J
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897708
[TBL] [Abstract][Full Text] [Related]
26. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
Xu T; Liu P; Li Q; Shi C; Wang X
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
[TBL] [Abstract][Full Text] [Related]
28. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
Surmeli Z; Gursoy P; Erdogan AP; Bozkurt E; Atmaca H; Uzunoglu S; Sezgin C; Şanlı UA; Uslu R; Karaca B
Tumour Biol; 2016 Mar; 37(3):3665-73. PubMed ID: 26462835
[TBL] [Abstract][Full Text] [Related]
29. Sinomenine inhibits hypoxia induced breast cancer side population cells metastasis by PI3K/Akt/mTOR pathway.
Song L; Zhang H; Hu M; Liu C; Zhao Y; Zhang S; Liu D
Bioorg Med Chem; 2021 Feb; 31():115986. PubMed ID: 33412412
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings.
Li W; Sun Q; Song L; Gao C; Liu F; Chen Y; Jiang Y
Eur J Med Chem; 2017 Dec; 141():721-733. PubMed ID: 29107429
[TBL] [Abstract][Full Text] [Related]
31. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.
Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ
J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381
[TBL] [Abstract][Full Text] [Related]
32. Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway.
Sun Y; Xu Y; Xu J; Lu D; Wang J
Int J Clin Exp Pathol; 2015; 8(8):9081-8. PubMed ID: 26464650
[TBL] [Abstract][Full Text] [Related]
33. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
[TBL] [Abstract][Full Text] [Related]
34. Preclinical Evaluation of a Fluorine-18 (
Altine B; Gai Y; Han N; Jiang Y; Ji H; Fang H; Niyonkuru A; Bakari KH; Rajab Arnous MM; Liu Q; Zhang Y; Lan X
Mol Pharm; 2019 Nov; 16(11):4563-4571. PubMed ID: 31553879
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the effects of rapamycin on the mTOR pathway and apoptosis in metastatic and non-metastatic human breast cancer cell lines.
Ekizceli G; Uluer ET; Inan S
Bratisl Lek Listy; 2020; 121(4):308-315. PubMed ID: 32356448
[TBL] [Abstract][Full Text] [Related]
36. The effects of PKI-402 on breast tumor models' radiosensitivity via dual inhibition of PI3K/mTOR.
Gasimli R; Kayabasi C; Ozmen Yelken B; Asik A; Sogutlu F; Celebi C; Yilmaz Susluer S; Kamer S; Biray Avci C; Haydaroglu A; Gunduz C
Int J Radiat Biol; 2023; 99(12):1961-1970. PubMed ID: 37389464
[TBL] [Abstract][Full Text] [Related]
37. 3-Epipachysamine B suppresses proliferation and induces apoptosis of breast cancer cell via PI3K/AKT/mTOR signaling pathway.
Zhang L; Zheng Y; Zeng L; Zhang F; Che D; Cao Z; Huang C; Xian L; Zhang X; Zhang H; Guo Z
Life Sci; 2021 Nov; 285():119995. PubMed ID: 34592228
[TBL] [Abstract][Full Text] [Related]
38. KRAS gene silencing inhibits the activation of PI3K-Akt-mTOR signaling pathway to regulate breast cancer cell epithelial-mesenchymal transition, proliferation and apoptosis.
Zhang Y; Liu JL; Wang J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3085-3096. PubMed ID: 32271426
[TBL] [Abstract][Full Text] [Related]
39. Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway.
Xu HY; Chen ZW; Hou JC; Du FX; Liu JC
Oncol Rep; 2013 Jan; 29(1):212-8. PubMed ID: 23129237
[TBL] [Abstract][Full Text] [Related]
40. Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells.
Farrash WF; Aslam A; Almaimani R; Minshawi F; Almasmoum H; Alsaegh A; Iqbal MS; Tabassum A; Elzubier ME; El-Readi MZ; Mahbub AA; Idris S; Refaat B
Biofactors; 2023; 49(4):831-848. PubMed ID: 36929658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
